RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

The endoplasmic reticulum (ER) is the portion of the cell responsible for manufacturing and folding proteins. Proteins are ...

By investigating how lipid-soluble Cer is transported between cells, the researchers demonstrated that high-density lipoprotein (HDL) serves as the primary carrier for Cer transport. Upon reaching ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...

Using lipidomics analysis and functional validation, they identified Cer as the key effector molecule responsible for this process. Further investigation revealed that the UPR pathway in ...

UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ ...

IgE and IgA antibodies have distinct and potent immunological effector functions predominantly ... different isotypes into a single antibody molecule with enhanced functionality.